MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells

Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1

(2014) J Bageritz et al.   CELL DEATH AND DIFFERENTIATION

TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer

(2014) Yueyun Ma et al.   GENE

Antagonistic Interplay between Necdin and Bmi1 Controls Proliferation of Neural Precursor Cells in the Embryonic Mouse Neocortex

(2014) Ryohei Minamide et al.   PLoS One

Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer

(2013) Xiaoqi Xie et al.   CANCER BIOLOGY & THERAPY

The Antidiabetic Drug Metformin Inhibits the Proliferation of Bladder Cancer Cells in Vitro and in Vivo

(2013) Tao Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma

(2013) Yong Guo et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells

(2013) Bingxiang Xiao et al.   Journal of Translational Medicine

Functional Profiling of Precursor MicroRNAs Identifies MicroRNAs Essential for Glioma Proliferation

(2013) Saija Haapa-Paananen et al.   PLoS One

Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A

(2013) Sining Shen et al.   TUMOR BIOLOGY

Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298

(2012) Lili Bao et al.   AMERICAN JOURNAL OF PATHOLOGY

MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2

(2012) Yi Yang et al.   FEBS LETTERS

Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 Protein in Human Melanoma Cells

(2012) Shunsuke Noguchi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death

(2012) Arin B. Aurora et al.   JOURNAL OF CLINICAL INVESTIGATION

Maintenance of muscle stem-cell quiescence by microRNA-489

(2012) Tom H. Cheung et al.   NATURE

Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors

(2012) T. S. Armstrong et al.   NEURO-ONCOLOGY

Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM

(2012) Dejuan Kong et al.   PLoS One

MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1

(2011) Bing Feng et al.   CANCER LETTERS

Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression

(2011) B. Bao et al.   CANCER RESEARCH

Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway

(2011) R. Hamano et al.   CLINICAL CANCER RESEARCH

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

(2011) B. B. Friday et al.   NEURO-ONCOLOGY

Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma

(2011) A. Baraniskin et al.   NEURO-ONCOLOGY

miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ

(2011) C Quintavalle et al.   ONCOGENE

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1

(2011) L Sun et al.   ONCOGENE

Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression

(2009) Z L Wu et al.   CELL DEATH AND DIFFERENTIATION

Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues

(2008) Junming Guo et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY